Severe dependency on zolpidem in a patient with multiple sclerosis suffering from paraspasticity

World Journal of Biological Psychiatry

Volumn 11, Issue 2 PART 2, 2010, Pages 516-518

  Damm, Julia ^a   Eser, Daniela ^a   Moeller, Hans Juergen ^a   Rupprecht, Rainer ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Dependency; Multiple sclerosis; Myorelaxation; Zolpidem

Indexed keywords

CARBAMAZEPINE; DIAZEPAM; DOXEPIN; TOLPERISONE; ZOLPIDEM;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DRUG DEPENDENCE; FEMALE; HOSPITAL ADMISSION; HUMAN; MULTIPLE SCLEROSIS; MUSCLE RELAXATION; SPASTICITY;

FEMALE; GABA AGONISTS; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MUSCLE SPASTICITY; PYRIDINES; SUBSTANCE-RELATED DISORDERS;

EID: 77950795872     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970903369973     Document Type: Article

References (19)

1. Beiske AG, Pedersen ED, Czujko B, Myhr KM. 2004. Pain and sensory complaints in multiple sclerosis. Eur J Neurol 11: 479-482.
2. Clauss R, Sathekge M, Nel W. 2004. Transient improvement of spinocerebellar ataxia with zolpidem. New Engl J Med 351:511-512.
3. Cohen L, Chaaban B, Habert MO. 2004. Transient improvement of aphasia with zolpidem. New Engl J Med 350:949-950.
4. Crestani F, Low K, Keist R, Mandelli M, Mohler H, Rudolph U. 2001. Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 59:442-445.
5. Cubala WJ, Landowski J. 2007. Seizure following sudden zolpidem withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 31:539-540.
6. Deutsche Gesellschaft fr Neurologie. 2009. Insomnie. Stuttgart: Georg Thieme. p 654ff.
7. Dundar Y, Boland A, Strobl J, Dodd S, Haycox A, Bagust A, et al. 2004. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technol Assess 8:iii-125.
8. Farver DK, Khan MH. 2001. Zolpidem for antipsychotic-induced parkinsonism. Ann Pharmacother 35:435-437.
9. Finger S. 1998. A happy state of mind: a history of mild elation, denial of disability, optimism, and laughing in multiple sclerosis. Arch Neurol 55:241-250.
10. Hajak G, Muller WE, Wittchen HU, Pittrow D, Kirch W. 2003. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98:1371-1378.
11. Hoffmann F, Pfannkuche M, Glaeske G. 2008. [High usage of zolpidem and zopiclone. Cross-sectional study using claims data]. Nervenarzt 79:67-72.
12. Hoffmann F, Scharffetter W, Glaeske G. 2009. [Use of zolpidem and zopiclone on private prescriptions between 1993 and 2007]. Nervenarzt 80:578-583.
13. Huang MC, Lin HY, Chen CH. 2007. Dependence on zolpidem. Psychiatry Clin Neurosci 61:207-208.
14. Liappas IA, Malitas PN, Dimopoulos NP, Gitsa OE, Liappas AI, Nikolaou C, et al. 2003. Zolpidem dependence case series: possible neurobiological mechanisms and clinical management. J Psychopharmacol. 17:131-135.
15. NICE-National Institute for Clinical Excellence 2004. Guidance on the use of zaleplone, zolpidem and zopiclone for the short term management of insomnia. Technology Appraisal Guidance ed. London: NICE.
16. Perrault G, Morel E, Sanger DJ, Zivkovic B. 1992. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J Pharmacol Exp Ther 263:298-303.
17. Ruzicka E, Roth J, Jech R, Busek P. 2000. Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease. Mov Disord 15:734-735.
18. Shadan FF, Poceta JS, Kline LE. 2004. Zolpidem for postanoxic spasticity. South Med J 97:791-792.
19. Wang WT, Chen YY, Wu SL, Wei TS, Liu SY. 2007. Zolpidem dramatically improved motor and speech function in a patient with central pontine myelinolysis. Eur J Neurol 14:e9-10.